粪钙卫蛋白检测市场：依检测类型、依适应症、依最终用户、按地区

全球粪便钙卫蛋白检测市场预计将从 2023 年的 1.228 亿美元增加到 2030 年的 2.766 亿美元，2023-2030 年预测期间复合年增长率为 12.3%。

图 1. 2023 年粪钙卫蛋白检测的全球市场占有率(%)（按地区）

消化器官系统发炎是由一种称为发炎性肠道疾病（IBD）的慢性疾病引起的。肠道中的白血球在粪便中释放一种称为钙卫蛋白的蛋白质。它在 IBD 患者中升高，使其成为识别和追踪疾病的有用生物标记。

市场动态：

胃肠道疾病盛行率的增加、认识的提高和早期检测、非侵入性和便捷的检测预计将在预测期内推动全球粪便钙卫蛋白检测市场的成长。此外，医疗保健提供者预计将越来越多地采用粪钙卫蛋白测试市场也将在预测期内促进全球粪便钙卫蛋白测试市场的成长。新兴市场、即时检测、家庭检测套组以及与数位健康技术选项的整合预计将为预测期内全球粪便钙卫蛋白检测市场提供成长机会。

然而，有限的报销范围、成本考虑、检测结果的可变性、有限的意识和医生知识预计将阻碍预测期内全球粪便钙卫蛋白检测市场的成长。

本研究的主要特点

• 该报告详细分析了粪便钙卫蛋白检测的全球市场，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和复合年增长率。
• 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球粪钙卫蛋白测试市场的主要企业。
• 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
• 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球粪便钙卫蛋白测试市场的各种策略矩阵来促进他们的决策。

第一章 研究目的与前提

• 研究目标
• 假设
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 胃肠道疾病盛行率增加
  • 粪便钙卫蛋白检测的报销范围可能有限
  • 与数位健康科技整合
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章全球粪钙卫蛋白检测市场 - 冠状冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球粪便钙卫蛋白检测市场，依检测类型，2018-2030

• 酵素结合免疫吸附测定法 (ELISA)
• 酵素氟化物免疫检测
• 定量层析法

第六章 2018-2030 年全球粪钙卫蛋白检测市场（依适应症）

• 发炎性肠道疾病（IBD）的诊断
• 大肠直肠癌
• 乳糜泻
• 其他的

第 7 章全球粪钙卫蛋白检测市场，依最终用户划分，2018-2030 年

• 医院
• 诊断实验室
• 学术研究所
• 其他的

第八章2018-2030年全球粪钙卫蛋白检测市场（按地区）

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 法国
• 西班牙
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东和非洲
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第9章竞争形势

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Abbexa Limited
• Bioserv Diagnostics Gmbh
• Epitope Diagnostics, Inc.
• LifeSpan BioSciences, Inc.
• RayBiotech, Inc.
• ALPCO

第10章

• 调查方法
• 关于出版商

The global fecal calprotectin test market is projected to reach US$ 276.6 million by 2030, from US$ 122.8 million in 2023, at a CAGR of 12.3% during the forecast period 2023-2030.

Figure 1. Global Fecal Calprotectin Test Market Share (%), by Region, 2023

Inflammation of the digestive system is brought on by the chronic illness of Inflammatory bowel disease (IBD). White blood cells in the intestines release a protein called fecal calprotectin. It is high in IBD patients, making it a helpful biomarker for identifying and tracking the condition.

Market Dynamics:

The increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing are anticipated to drive growth of the global fecal calprotectin test market over the forecast period. Moreover, increasing adoption by healthcare providers is also expected to boost growth of the global fecal calprotectin test market over the forecast period. Emerging markets, point-of-care testing, home-based testing kits, and integration with digital health technology options are expected to create growth opportunities for the global fecal calprotectin test market during the forecast period.

However, limited reimbursement coverage, cost considerations, variability in test results, and limited awareness and physician knowledge are expected to hamper growth of the global fecal calprotectin test market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global fecal calprotectin test market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global fecal calprotectin test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbexa Limited, Bioserv Diagnostics Gmbh, Epitope Diagnostics, Inc., LifeSpan BioSciences, Inc., RayBiotech, Inc., ALPCO
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global fecal calprotectin test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders have ease in decision-making through various strategy matrices used in analyzing the would global fecal calprotectin test market

Detailed Segmentation:

• By Assay Type:
  • Enzyme Linked Immunosorbent Assay (ELISA)
  • Enzyme Fluoroimmunoassay
  • Quantitative Immune-Chromatography
• By Indication:
  • Inflammatory Bowel Disease (IBD) Diagnosis
  • Colorectal Cancer
  • Celiac Disease
  • Others
• By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others
• By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East
  • Africa
• Top companies in Fecal Calprotectin Test Market
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbexa Limited
  • Bioserv Diagnostics Gmbh
  • Epitope Diagnostics, Inc.
  • LifeSpan BioSciences, Inc.
  • RayBiotech, Inc.
  • ALPCO

Table of Content

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market global fecal calprotectin test, By Assay Type
  • Market global fecal calprotectin test, By Indication
  • Market global fecal calprotectin test, By End User
  • Market global fecal calprotectin test, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of gastrointestinal disorders
  • Rreimbursement coverage for Fecal Calprotectin Tests may be limited
  • Integration with digital health technologies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Fecal Calprotectin Test Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Fecal Calprotectin Test Market, By Assay Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Enzyme Linked Immunosorbent Assay (ELISA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Enzyme Fluoroimmunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Quantitative Immune-Chromatography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Fecal Calprotectin Test Market, By Indication, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Inflammatory Bowel Disease (IBD) Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Colorectal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Celiac Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Global Fecal Calprotectin Test Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Global Fecal Calprotectin Test Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Germany
• U.K.
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Abbexa Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bioserv Diagnostics Gmbh
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Epitope Diagnostics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• LifeSpan BioSciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RayBiotech, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ALPCO
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us